Goldman Sachs
GLSI icon

Goldman Sachs’s Greenwich LifeSciences GLSI Stock Holding History

Goldman Sachs’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$949K Buy
39,521
+17,976
+83% +$469K ﹤0.01% 5126
2025
Q4 		$453K Buy
21,545
+1,700
+9% +$17.9K ﹤0.01% 5652
2025
Q3 		$197K Buy
19,845
+3,347
+20% +$37.8K ﹤0.01% 5957
2025
Q2 		$150K Buy
+16,498
New +$157K ﹤0.01% 5738
2025
Q1 		– Sell
-15,070
Closed -$169K – 6198
2024
Q4 		$169K Buy
+15,070
New +$202K ﹤0.01% 5684
2024
Q2 		– Sell
-41,505
Closed -$828K – 5752
2024
Q1 		$828K Buy
+41,505
New +$512K ﹤0.01% 4461
2022
Q3 		– Sell
-12,322
Closed -$104K – 6377
2022
Q2 		$104K Buy
+12,322
New +$141K ﹤0.01% 5852

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Goldman Sachs's GLSI Position: Q1 2026 in Review

Goldman Sachs increased its Greenwich LifeSciences (GLSI) stake by 83% in Q1 2026, buying an estimated $469K and bringing the position to 39,521 shares worth $949K. The position accounts for ﹤0.01% of the portfolio, ranked #5126.

Goldman Sachs first reported a position in GLSI in Q2 2022 and has held it in 7 quarters since. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • Goldman Sachs held 39,521 shares of Greenwich LifeSciences worth $949K as of Q1 2026.
  • Goldman Sachs bought 17,976 Greenwich LifeSciences shares in Q1 2026, an estimated $469K.
  • Greenwich LifeSciences made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5126 holding.
  • Goldman Sachs first reported a position in Greenwich LifeSciences in Q2 2022 and has held it in 7 quarters since.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.